Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease
Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p2...
Saved in:
| Published in: | PloS one Vol. 8; no. 9; p. e72904 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Public Library of Science
23.09.2013
Public Library of Science (PLoS) |
| Subjects: | |
| ISSN: | 1932-6203, 1932-6203 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD.
Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively.
In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation.
The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. |
|---|---|
| AbstractList | Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD. Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively. In the first cohort there was little cell cycle progression beyond G.sub.1 /S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation. The findings are consistent with impaired cell cycle progression beyond the G.sub.1 /S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. Background and aimAlcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD.MethodsLiver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively.ResultsIn the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation.ConclusionsThe findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. Background and Aim Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD. Methods Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and “normal” liver sections (n=5) served as positive and negative controls, respectively. Results In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation. Conclusions The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. Background and Aim Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD. Methods Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and “normal” liver sections (n=5) served as positive and negative controls, respectively. Results In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation. Conclusions The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD.BACKGROUND AND AIMAlcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD.Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively.METHODSLiver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively.In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation.RESULTSIn the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation.The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD.CONCLUSIONSThe findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD. Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively. In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation. The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. Background and Aim Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD. Methods Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively. Results In the first cohort there was little cell cycle progression beyond G.sub.1 /S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation. Conclusions The findings are consistent with impaired cell cycle progression beyond the G.sub.1 /S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD. |
| Audience | Academic |
| Author | Pietrosi, Giada Alexander, Graeme J. M. Sheron, Nick Jupp, James Marshall, Aileen Aravinthan, Aloysious Hoare, Matthew Bateman, Adrian Verrill, Clare Allison, Michael Davies, Susan |
| AuthorAffiliation | Bambino Gesu' Children Hospital, Italy 1 Department of Medicine, University of Cambridge, Cambridge, United Kingdom 3 Department of Hepatology, University Hospital Southampton, Southampton, United Kingdom 4 Department of Histopathology, Cambridge University Hospital, Cambridge, United Kingdom 2 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom 5 Department of Histopathology, University Hospital Southampton, Southampton, United Kingdom |
| AuthorAffiliation_xml | – name: 1 Department of Medicine, University of Cambridge, Cambridge, United Kingdom – name: 5 Department of Histopathology, University Hospital Southampton, Southampton, United Kingdom – name: 3 Department of Hepatology, University Hospital Southampton, Southampton, United Kingdom – name: Bambino Gesu' Children Hospital, Italy – name: 2 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom – name: 4 Department of Histopathology, Cambridge University Hospital, Cambridge, United Kingdom |
| Author_xml | – sequence: 1 givenname: Aloysious surname: Aravinthan fullname: Aravinthan, Aloysious – sequence: 2 givenname: Giada surname: Pietrosi fullname: Pietrosi, Giada – sequence: 3 givenname: Matthew surname: Hoare fullname: Hoare, Matthew – sequence: 4 givenname: James surname: Jupp fullname: Jupp, James – sequence: 5 givenname: Aileen surname: Marshall fullname: Marshall, Aileen – sequence: 6 givenname: Clare surname: Verrill fullname: Verrill, Clare – sequence: 7 givenname: Susan surname: Davies fullname: Davies, Susan – sequence: 8 givenname: Adrian surname: Bateman fullname: Bateman, Adrian – sequence: 9 givenname: Nick surname: Sheron fullname: Sheron, Nick – sequence: 10 givenname: Michael surname: Allison fullname: Allison, Michael – sequence: 11 givenname: Graeme J. M. surname: Alexander fullname: Alexander, Graeme J. M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24086266$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk21r2zAQx83oWB-2bzA2wWBsL5LJlmzZezEoXbsGMgrttrfiIp0TtY6VWXJpv8Q-8y5NGppSxjDmxOl3__Od7_aTnda3mCSvUz5MhUo_Xfq-a6EZLsg95FxlFZfPkr20EtmgyLjYeXDeTfZDuOQ8F2VRvEh2M8nLIiuKveTPKS4genMbkR3fLDoMwfmW-ZrFGbILbDEYbA2y79BdYccWWcpGgY1de4WWRc9O3KTzwQUGraWXHdpr7AISQXZwjg1EAs_6aPwcmSOgMX7mm83VHci-uoAQ8GXyvIYm4Ku1PUh-nhz_ODodjM--jY4OxwOj8jIOEEq0UqWWY1VgYY2yHDKp6gnkBnmOMrMlQGFVlUElcsNBiIksMqSiBTfiIHm70l00Puh1K4NOpcilSHlaEjFaEdbDpV50bg7drfbg9J3Dd1MNXXSmQV2rCUBZWaVULnNOiescFBlR2zKrJqT1ZZ2tn8zRUkNjB82W6PZN62Z66q-1UGWaCkkCH9YCnf_dY4h67ui_NA206Pvld0shqrKQFaHvHqFPV7empkAFuLb2lNcsRfWhpKQiU3lB1PAJih6Lc2do7mpH_q2Aj1sBxES8iVPoQ9Cji_P_Z89-bbPvH7AzhCbOgm_6SLMatsE3Dzu9afH9wBMgV4ChqQ0d1hsk5Xq5V_ft0su90uu9orDPj8KMi7BMTx1xzb-D_wKdHilY |
| CitedBy_id | crossref_primary_10_1111_jvim_15238 crossref_primary_10_1016_j_exger_2014_09_011 crossref_primary_10_1080_14728222_2021_1992385 crossref_primary_10_1155_2022_1059257 crossref_primary_10_3390_medicina60030429 crossref_primary_10_4103_2221_1691_383689 crossref_primary_10_3390_cells10061278 crossref_primary_10_1111_iep_12272 crossref_primary_10_3390_cancers9100130 crossref_primary_10_3390_biom6020017 crossref_primary_10_1038_s41536_024_00371_1 crossref_primary_10_3390_ijms15058591 crossref_primary_10_1007_s11357_025_01539_3 crossref_primary_10_1038_s41379_021_00940_5 crossref_primary_10_1016_j_csbj_2019_07_021 crossref_primary_10_1016_j_jhep_2025_08_021 crossref_primary_10_1038_s41392_023_01502_8 crossref_primary_10_1097_HEP_0000000000000986 crossref_primary_10_1097_HEP_0000000000000426 crossref_primary_10_3390_livers5010005 crossref_primary_10_1016_j_yexmp_2017_01_003 crossref_primary_10_1038_s41575_024_00913_4 crossref_primary_10_1016_S1001_9294_16_30036_0 crossref_primary_10_1097_HC9_0000000000000350 crossref_primary_10_4161_cc_28471 crossref_primary_10_1111_apt_14802 crossref_primary_10_1080_17474124_2024_2432480 crossref_primary_10_3390_livers2040023 crossref_primary_10_18632_oncotarget_6382 crossref_primary_10_1055_s_0040_1722262 crossref_primary_10_1136_gutjnl_2024_334094 crossref_primary_10_1016_j_yexcr_2014_09_025 crossref_primary_10_3390_ijms222212545 crossref_primary_10_1038_s41598_017_11756_2 crossref_primary_10_1111_wrr_12763 crossref_primary_10_1016_j_lfs_2020_117776 crossref_primary_10_1080_15376516_2024_2365431 crossref_primary_10_1016_j_ajpath_2017_11_016 crossref_primary_10_1038_s41575_019_0165_3 crossref_primary_10_1007_s12011_024_04255_9 crossref_primary_10_1016_j_freeradbiomed_2025_08_006 crossref_primary_10_1016_j_biopha_2017_11_075 crossref_primary_10_1016_j_mam_2025_101397 crossref_primary_10_1002_cbin_10706 crossref_primary_10_1101_gad_267724_115 crossref_primary_10_1016_j_jnutbio_2021_108861 crossref_primary_10_1038_s41419_021_04442_9 crossref_primary_10_1016_j_phymed_2025_156522 crossref_primary_10_1002_wrna_1547 crossref_primary_10_1002_ctm2_1276 crossref_primary_10_1053_j_gastro_2025_06_010 crossref_primary_10_7554_eLife_63835 crossref_primary_10_1016_j_lfs_2017_10_023 crossref_primary_10_1093_nar_gkz555 crossref_primary_10_3390_toxics12120856 crossref_primary_10_3748_wjg_v21_i41_11522 crossref_primary_10_1016_j_tem_2025_08_003 crossref_primary_10_1371_journal_pone_0096124 crossref_primary_10_1016_j_jhepr_2025_101478 crossref_primary_10_1016_j_intimp_2024_112938 crossref_primary_10_3389_fphar_2023_1194343 crossref_primary_10_1038_s41467_025_63251_2 crossref_primary_10_1016_j_intimp_2023_110497 crossref_primary_10_1097_IGC_0000000000001257 crossref_primary_10_1007_s11684_025_1133_7 crossref_primary_10_1002_1878_0261_13685 crossref_primary_10_1002_hep_29581 crossref_primary_10_1016_j_alcohol_2022_05_004 crossref_primary_10_1016_j_jhep_2016_05_030 crossref_primary_10_3389_fphar_2022_912825 crossref_primary_10_1136_bmj_2023_077090 crossref_primary_10_3390_cells11142221 crossref_primary_10_3748_wjg_v20_i47_17851 crossref_primary_10_1016_j_cgh_2022_05_020 crossref_primary_10_1371_journal_pone_0127511 crossref_primary_10_1016_j_lfs_2021_119997 crossref_primary_10_1007_s13577_015_0110_x crossref_primary_10_3892_etm_2019_8037 crossref_primary_10_1016_j_ajpath_2017_08_027 crossref_primary_10_1016_j_bbrc_2019_03_021 crossref_primary_10_1038_ncb3203 |
| Cites_doi | 10.1056/NEJMra0805786 10.1038/nrc2440 10.1080/00365520410006350 10.1016/j.jhep.2012.04.004 10.1007/s12032-012-0357-y 10.1126/science.274.5293.1672 10.1016/0376-8716(88)90018-X 10.1002/hep.20957 10.1016/j.jhep.2012.10.031 10.1016/j.jhep.2012.05.013 10.1002/hep.23258 10.1016/j.biocel.2004.10.013 10.1002/hep.25703 10.1242/jcs.115.14.2829 10.1053/j.gastro.2011.09.002 10.1038/nrm2233 10.1073/pnas.92.10.4337 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2013 Public Library of Science 2013 Aravinthan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2013 Aravinthan et al 2013 Aravinthan et al |
| Copyright_xml | – notice: COPYRIGHT 2013 Public Library of Science – notice: 2013 Aravinthan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2013 Aravinthan et al 2013 Aravinthan et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0072904 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Medicine |
| DocumentTitleAlternate | Hepatocyte Senescence in ALD |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1435431018 oai_doaj_org_article_f7baa89d77754508aaf5a78aa3fd829b PMC3781134 3079839691 A478132756 24086266 10_1371_journal_pone_0072904 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom--UK |
| GeographicLocations_xml | – name: United Kingdom--UK |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACCTH ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PYCSY RIG RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM ALIPV CGR CUY CVF ECM EIF NPM PV9 RZL BBORY 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO ESTFP FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 PUEGO 5PM AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c758t-ea8ed471d0e96e6dc7d0a247fba5ce05e42d8aa6d792a935c0a33b462e26630c3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 91 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000326520200004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1932-6203 |
| IngestDate | Sun Apr 02 01:15:51 EDT 2023 Mon Nov 10 04:35:24 EST 2025 Tue Nov 04 01:41:52 EST 2025 Thu Oct 02 10:51:26 EDT 2025 Tue Oct 07 07:12:53 EDT 2025 Sat Nov 29 13:19:26 EST 2025 Sat Nov 29 09:48:20 EST 2025 Wed Nov 26 09:21:41 EST 2025 Wed Nov 26 10:41:34 EST 2025 Thu May 22 21:17:32 EDT 2025 Mon Jul 21 06:04:20 EDT 2025 Sat Nov 29 03:20:03 EST 2025 Tue Nov 18 22:19:02 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c758t-ea8ed471d0e96e6dc7d0a247fba5ce05e42d8aa6d792a935c0a33b462e26630c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceived and designed the experiments: AA GA. Performed the experiments: AA GP. Analyzed the data: AA MA. Contributed reagents/materials/analysis tools: AA GP MH AM JJ CV SD AB MA. Wrote the manuscript: AA GA. Acquisition of data: AA JJ CV. Provision of clinical data: NS MA. Drafting of the manuscript: AA. Histological interpretation: SD AB. Critical review of the manuscript: MA GA. Technical assistance and review of manuscript: GP MA AM. Overall supervision of the study: GA. Competing Interests: The authors have declared that no competing interests exist. |
| OpenAccessLink | https://doaj.org/article/f7baa89d77754508aaf5a78aa3fd829b |
| PMID | 24086266 |
| PQID | 1435431018 |
| PQPubID | 1436336 |
| PageCount | e72904 |
| ParticipantIDs | plos_journals_1435431018 doaj_primary_oai_doaj_org_article_f7baa89d77754508aaf5a78aa3fd829b pubmedcentral_primary_oai_pubmedcentral_nih_gov_3781134 proquest_miscellaneous_1443398649 proquest_journals_1435431018 gale_infotracmisc_A478132756 gale_infotracacademiconefile_A478132756 gale_incontextgauss_ISR_A478132756 gale_incontextgauss_IOV_A478132756 gale_healthsolutions_A478132756 pubmed_primary_24086266 crossref_primary_10_1371_journal_pone_0072904 crossref_citationtrail_10_1371_journal_pone_0072904 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-09-23 |
| PublicationDateYYYYMMDD | 2013-09-23 |
| PublicationDate_xml | – month: 09 year: 2013 text: 2013-09-23 day: 23 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2013 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | A Aravinthan (ref12) 2013; 58 K Tomita (ref16) 2012; 57 CJ Sherr (ref14) 1996; 274 F Borel (ref15) 2002; 115 B Gao (ref1) 2011; 141 E González-Reimers (ref7) 1988; 22 F d’Adda di Fagagna (ref10) 2008; 8 A Ozen (ref11) 2013; 30 GK Michalopoulos (ref17) 2012; 55 H Bell (ref6) 2004; 39 A Dey (ref4) 2006; 43 I Ben-Porath (ref8) 2005; 37 Q Chen (ref13) 1995; 92 RS O’Shea (ref2) 2010; 51 European Association For The Study Of The L (ref3) 2012; 57 J Campisi (ref18) 1998; 3 MR Lucey (ref5) 2009; 360 J Campisi (ref9) 2007; 8 3234242 - Drug Alcohol Depend. 1988 Dec;22(3):195-203 16447273 - Hepatology. 2006 Feb;43(2 Suppl 1):S63-74 12082144 - J Cell Sci. 2002 Jul 15;115(Pt 14):2829-38 22407729 - Hepatology. 2012 Jun;55(6):2024-7 7753808 - Proc Natl Acad Sci U S A. 1995 May 9;92(10):4337-41 15743671 - Int J Biochem Cell Biol. 2005 May;37(5):961-76 18574463 - Nat Rev Cancer. 2008 Jul;8(7):512-22 17667954 - Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40 23142622 - J Hepatol. 2013 Mar;58(3):549-56 21920463 - Gastroenterology. 2011 Nov;141(5):1572-85 19553649 - N Engl J Med. 2009 Jun 25;360(26):2758-69 22641095 - J Hepatol. 2012 Oct;57(4):837-43 9732048 - J Investig Dermatol Symp Proc. 1998 Aug;3(1):1-5 23275116 - Med Oncol. 2013 Mar;30(1):357 8939849 - Science. 1996 Dec 6;274(5293):1672-7 20034030 - Hepatology. 2010 Jan;51(1):307-28 15513384 - Scand J Gastroenterol. 2004 Sep;39(9):858-63 22633836 - J Hepatol. 2012 Aug;57(2):399-420 |
| References_xml | – volume: 3 start-page: 1 year: 1998 ident: ref18 article-title: The role of cellular senescence in skin aging publication-title: J Investig Dermatol Symp Proc – volume: 360 start-page: 2758 year: 2009 ident: ref5 article-title: Alcoholic hepatitis publication-title: N Engl J Med doi: 10.1056/NEJMra0805786 – volume: 8 start-page: 512 year: 2008 ident: ref10 article-title: Living on a break: cellular senescence as a DNA-damage response publication-title: Nat Rev Cancer doi: 10.1038/nrc2440 – volume: 39 start-page: 858 year: 2004 ident: ref6 article-title: Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit publication-title: Scand J Gastroenterol doi: 10.1080/00365520410006350 – volume: 57 start-page: 399 year: 2012 ident: ref3 article-title: EASL Clinical Practical Guidelines: Management of alcoholic Liver Disease publication-title: J Hepatol doi: 10.1016/j.jhep.2012.04.004 – volume: 30 start-page: 357 year: 2013 ident: ref11 article-title: The prognostic significance of p21 and Her-2 gene expression and mutation/polymorphism in patients with gastric adenocarcinoma publication-title: Med Oncol doi: 10.1007/s12032-012-0357-y – volume: 274 start-page: 1672 year: 1996 ident: ref14 article-title: Cancer cell cycles publication-title: Science doi: 10.1126/science.274.5293.1672 – volume: 22 start-page: 195 year: 1988 ident: ref7 article-title: Hepatocyte and nuclear areas and fatty infiltration of the liver in chronic alcoholic liver disease publication-title: Drug Alcohol Depend doi: 10.1016/0376-8716(88)90018-X – volume: 43 start-page: S63 year: 2006 ident: ref4 article-title: Alcohol and oxidative liver injury publication-title: Hepatology doi: 10.1002/hep.20957 – volume: 58 start-page: 549 year: 2013 ident: ref12 article-title: Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2012.10.031 – volume: 57 start-page: 837 year: 2012 ident: ref16 article-title: p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice publication-title: J Hepatol doi: 10.1016/j.jhep.2012.05.013 – volume: 51 start-page: 307 year: 2010 ident: ref2 article-title: Alcoholic liver disease publication-title: Hepatology doi: 10.1002/hep.23258 – volume: 37 start-page: 961 year: 2005 ident: ref8 article-title: The signals and pathways activating cellular senescence publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2004.10.013 – volume: 55 start-page: 2024 year: 2012 ident: ref17 article-title: Phenotypic fidelity (or not?) of epithelial cells in the liver publication-title: Hepatology doi: 10.1002/hep.25703 – volume: 115 start-page: 2829 year: 2002 ident: ref15 article-title: Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis publication-title: J Cell Sci doi: 10.1242/jcs.115.14.2829 – volume: 141 start-page: 1572 year: 2011 ident: ref1 article-title: Alcoholic liver disease: pathogenesis and new therapeutic targets publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.09.002 – volume: 8 start-page: 729 year: 2007 ident: ref9 article-title: Cellular senescence: when bad things happen to good cells publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2233 – volume: 92 start-page: 4337 year: 1995 ident: ref13 article-title: Oxidative DNA damage and senescence of human diploid fibroblast cells publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.92.10.4337 – reference: 22641095 - J Hepatol. 2012 Oct;57(4):837-43 – reference: 23142622 - J Hepatol. 2013 Mar;58(3):549-56 – reference: 7753808 - Proc Natl Acad Sci U S A. 1995 May 9;92(10):4337-41 – reference: 22633836 - J Hepatol. 2012 Aug;57(2):399-420 – reference: 16447273 - Hepatology. 2006 Feb;43(2 Suppl 1):S63-74 – reference: 15513384 - Scand J Gastroenterol. 2004 Sep;39(9):858-63 – reference: 21920463 - Gastroenterology. 2011 Nov;141(5):1572-85 – reference: 23275116 - Med Oncol. 2013 Mar;30(1):357 – reference: 8939849 - Science. 1996 Dec 6;274(5293):1672-7 – reference: 15743671 - Int J Biochem Cell Biol. 2005 May;37(5):961-76 – reference: 17667954 - Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40 – reference: 3234242 - Drug Alcohol Depend. 1988 Dec;22(3):195-203 – reference: 18574463 - Nat Rev Cancer. 2008 Jul;8(7):512-22 – reference: 9732048 - J Investig Dermatol Symp Proc. 1998 Aug;3(1):1-5 – reference: 12082144 - J Cell Sci. 2002 Jul 15;115(Pt 14):2829-38 – reference: 20034030 - Hepatology. 2010 Jan;51(1):307-28 – reference: 19553649 - N Engl J Med. 2009 Jun 25;360(26):2758-69 – reference: 22407729 - Hepatology. 2012 Jun;55(6):2024-7 |
| SSID | ssj0053866 |
| Score | 2.418254 |
| Snippet | Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol... Background and Aim Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and... Background and aimAlcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and... Background and Aim Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e72904 |
| SubjectTerms | Adult Aged Alcohol use Alcohols Automation Biomarkers - metabolism Biopsy Cell activation Cell cycle Cellular Senescence Cirrhosis Cohort Studies Cyclin-dependent kinase inhibitor p21 Cyclin-Dependent Kinase Inhibitor p21 - metabolism Drinking (Alcoholic beverages) Fatty liver Female Fibrosis Gene expression Health aspects Hepatitis Hepatocytes - metabolism Hepatology Histology Histopathology Hospitals Humans Immunohistochemistry Liver Liver cancer Liver cirrhosis Liver Cirrhosis - metabolism Liver Cirrhosis - pathology Liver diseases Liver Diseases, Alcoholic - metabolism Liver Diseases, Alcoholic - pathology Liver transplants Male Markers Medical prognosis Medical research Medicine Metastasis Middle Aged Morbidity Mortality Patients Phase distribution Prognosis Rodents S phase Senescence |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELagILQXYOPHCgMMQgIewlI7jZMnNGDV9sA2MUB7iy62s1WaktKkCP4J_mbuHCcQNAESD1Wk-kta2-c7X3z3HWNPJxGEoKQNpmEhgkhMTAAxxEEaCYAoBQ2JccUm1MFBcnKSHvkXbrUPq-x0olPUptL0jnyb7Doau3CSvFp8DqhqFJ2u-hIal9kVYkmQLnTvqNPEuJbj2KfLSTXZ9rPzclGVtqXM9uXZOnPkWPt73TxanFf1RRvP3-MnfzFIsxv_25Wb7LrfivKdVnbW2SVbbrBr7_xh-wZb9-u-5s89OfWLW-z7HtqvptLfGst3v_oo2pJXBcedJD8mzanpJk5JQHbJF2LC92tOLq81vKn4DP3zqp7XHEqDH-4qQtcWEXgNXGweAg9XDfbF8jkC2iK-fZMD8rftwdJt9nG2--HNXuBrOgQaPZMmsJBYgwbRhDaNbWy0MiGISBU5TLUNpzYSJgGIjUoFpHKqQ5Ayj2JhcSchQy3vsFGJ87fJuI1zdO2l1jLMozyxIGKr6fE6Dw0oGDPZTW2mPeE51d04z9wpnkLHpx3ojAQi8wIxZkF_16Il_PgL_jVJTY8lum73RbU8zfzqzwqVAySpUcQ3iFtigGIKCi-yMIlI8zF7RDKXtbmvvdLJdigRWBJD_5g9cQii7CgpJugUVnWd7R9--gfQ8fsB6JkHFRUOhwafh4F9IiqwAXJrgETFowfNm7RCulGps59yjXd2kn9x8-O-mR5KcX6lrVaEiaSkigHpmN1tF1k_skTGh-43_q4aLL_B0A9byvmZY0yXlE8to3t__lv32ZpwxU7SQMgtNmqWK_uAXdVfmnm9fOhUyw8tAoWQ priority: 102 providerName: ProQuest – databaseName: Public Library of Science (PLoS) Journals Open Access dbid: FPL link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZQQYgXYOPHCgMMQgIeAqmd2snjgFWbBNvEAO0tutgOVJqSqkkR_BP8zdw5biDTJuChilR_TtOL73wn333H2NNJAjFo6aJpXIooERMbgQIVZYkASDIwkFrfbEIfHKQnJ9nR70DxzAm-1JNXQaYvF3XlOqJrov-8LKRSlMI1O3q3tryou0qF8riLZg62H8_S39vi0eK0bs5zNM_mS_6xAc1u_O-j32TXg6vJd7q1scEuuWqTXX0fDtM32UbQ64Y_D-TTL26xn3u4P7W1-dE6vvs9ZMlWvC45eor8mCyjoUmcinzcki_EhO83nEJaZ3lb8xnG33UzbzhUFj_cd3xuHCLwGvncOwQerlpc6o7PEdA16e2HPJC_7Q6ObrNPs92Pb_ai0LMhMhh5tJGD1Fnc8GzsMuWUNdrGIBJdFjA1Lp66RNgUQFmdCcjk1MQgZZEo4dBTkLGRd9ioQnFtMe5UgaG7NEbGRVKkDoRyhm5vitiChjGT61eZm0BoTn01TnN_SqcxsOkEnZP88yD_MYv6WYuO0OMv-Ne0Snos0XH7L_BF50G781IXAGlmNfEJossLUE5B40WWNhVZMWaPaI3lXW1rb1TyHSr0lcTAP2ZPPIIoOSrK-fkCq6bJ9w8__wPo-MMA9CyAyhrFYSDUWeB_IqqvAXJ7gETDYgbDW6QRa6k0ObnW6G_GkxRnrrXk_OHH_TDdlPL4KlevCJNISR0BsjG72ylVL1ki28PwGn9XD9RtIPrhSDX_6hnRJdVLy-TexU98n10TvpFJFgm5zUbtcuUesCvmWztvlg-9GfkFEBNz9A priority: 102 providerName: Public Library of Science |
| Title | Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24086266 https://www.proquest.com/docview/1435431018 https://www.proquest.com/docview/1443398649 https://pubmed.ncbi.nlm.nih.gov/PMC3781134 https://doaj.org/article/f7baa89d77754508aaf5a78aa3fd829b http://dx.doi.org/10.1371/journal.pone.0072904 |
| Volume | 8 |
| WOSCitedRecordID | wos000326520200004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals (DOAJ) customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: P5Z dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Agriculture Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M0K dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7P dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7S dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PATMY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KB. dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7RV dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PIMPY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: FPL dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELag8MALYvxaYRSDkICHbGmcxsnjOq3aNFaiDqayl-hiO1BpJFWTIvgn-Ju5S9xoQZPGAw-9SPHntL07n8-K_R1jb4Y-uCCFcUZu5jm-N9QOBBA4ke8B-BEoCHVdbEJOp-F8HsVXSn3RnrCGHrhR3F4mU4Aw0pKo2jCbAMhGIPEiMh16UUrRF7OezWKqicE4ioPAHpQTcrhn7bK7LHLTkGXbwmybiajm62-jcm95WZTXpZx_75y8MhVNHrD7Nofk-81v32K3TP6QbdlRWvJ3lkr6_SP2-whnm6pQvyrDzU-75zXnRcYx7-MlxTlFnfh32qWz4ktvyBclp7e6RvOq4BmuposSb0Gu8cOB6jeXBhF4deqDMAgs1hU6ruELBDQld9umGsjta6DH7PPk8NPBkWMrMDgK1xGVYyA0Gqcv7ZooMIFWUrvg-TJLYaSMOzK-p9EUgZaRB5EYKReESP3AMzjvC1eJJ6yXo863GTdBigtxoZRwUz8NDXiBUfR4lboaJPSZ2JgjUZaenKpkXCb1OzeJy5RGuwkZMbFG7DOn7bVs6DluwI_J0i2WyLXrG-hyiXW55CaX67OX5CdJc1K1DRHJPh3bFcSn32evawQRbOS0g-crrMsyOf54_g-gs1kH9NaCsgLVocCemsD_RMRdHeROB4lhQnWat8mrN1opE0qUMXt0hyH23Hj69c2v2mZ6KO3Ky02xJowvBPH7R332tBkYrWaJOg8Xy_i9sjNkOqrvtuSLbzW_uaDTz8J_9j9s9Zzd8-oCJpHjiR3Wq1Zr84LdVT-qRbkasNtydk5yLmsZogwPhgN2Z3w4jWeDOqignMQfUJ6Md1GeuickZVzLM5Tx6AJ7xMen8Zc_ltSDtw |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcAFaHl0oVCDQIVDaNbO5nFAqNBWXfWF2lL1Fia2U1aqkmWTBfon-Cn8RmYSJxBUAZceOKwirT9bu7PzsNcz8zH2tO-BC4E0zsBNheOJvnbAB9-JPAHgRaAg1BXZRLC7Gx4fR-9m2PemFobSKhufWDlqnSv6j3yF4joGO7cfvh5_cog1im5XGwqNWi22zNkXPLIVr4Zr-Ps-E2Jj_fDtpmNZBRyFe-PSMRAajS5Zuybyja9VoF0QXpAmMFDGHRhP6BDA10EkIJID5YKUiecLg7FMukriupfYZfTjfUohC_aPGs-PvsP3bXmeDPorVhtejvPM1C26LR1cE_4qloA2FsyOT_PivI3u7_mavwTAjZv_m-husRt2q81Xa9uYYzMmm2dXd2wywTybs36t4M9t8-0Xt9m3TYzPZa7OSsPXv9os4YznKcedMj-gyKBoEqciJzPhY9Hnw4LTkd5oXuZ8Y5Sg5EcFh0zji1eM14VBBD6dKvcQgXvTEmVn-AgBNUlxO1QB-Vp9cXaHvb8QEd1lsxnqywLjxk_8yJVKSTfxktCA8I2i5VXiagigx2SjSrGyDd2JV-Q0rm4pAzzY1YKOSQFjq4A95rSzxnVDk7_g35CWtlhqR169kU9OYuvd4jRIAMJIB9RPEbf8AOkAAnzIVIciSnpsiXQ8rmt7W6car1KhsyQGgh57UiGoJUlGOU8nMC2KeLh39A-gg_0OaNmC0hzFocDWmeB3olZnHeRiB4mOVXWGF8giG6kU8U87wpmNpZ0__LgdpkUpjzEz-ZQwnpTEiBD12L3aqFvJUrNBH7Wgx4KOuXdE3x3JRh-rjvCS6sWld__PH2uJXds83NmOt4e7Ww_YdVERu0SOkItstpxMzUN2RX0uR8XkUeXWOPtw0c7gBwD44-8 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VgiouQMujgUIXBAIOJs6u48cBodI2alRoKwqoNzPeXZdIlR1iB-if4Afx65ix1wajCrj0wCGylP3Wcsbz2M3OzMfYw4EHLgTSOEM3FY4nBtoBH3wn8gSAF4GCUFdkE8HeXnh0FB0ssO9NLQylVTY-sXLUOlf0H3mf4joGO3cQ9lObFnGwNXox_eQQgxSdtDZ0GrWK7JrTL7h9K56Pt_BdPxJitP12c8exDAOOwnVy6RgIjUb3rF0T-cbXKtAuCC9IExgq4w6NJ3QI4OsgEhDJoXJBysTzhcG4Jl0l8b4X2MVAohZTlfpmm16CfsT3bameDAZ9qxnPpnlm6nbdlhquCYUVY0AbFxanJ3lx1qL399zNX4Lh6Or_LMZr7IpdgvON2maW2YLJVtjSa5tksMKWrb8r-BPblPvpdfZtB-N2mavT0vDtrzZ7OON5ynEFzQ8pYiiaxKn4ycz4VAz4uOC01TealzkfTRJ8C5OCQ6bxwysm7MIgAq9OlZOIwP15iXI0fIKAmry4HaqAfKs-ULvB3p2LiG6yxQx1Z5Vx4yd-5EqlpJt4SWhA-EbR7VXiagigx2SjVrGyjd6Jb-Qkrk4vA9zw1YKOSRljq4w95rSzpnWjk7_gX5LGtlhqU159kc-OY-v14jRIAMJIB9RnEbcCAOkQArzIVIciSnpsnfQ9rmt-W2cbb1ABtCRmgh57UCGoVUlG2noM86KIx_vv_wF0-KYDemxBaY7iUGDrT_A3UQu0DnKtg0SHqzrDq2SdjVSK-KdN4czG6s4evt8O000pvzEz-ZwwnpTElBD12K3awFvJUhNCH7Wgx4KO6XdE3x3JJh-rTvGS6sild_vPj7XOltAHxK_Ge7t32GVR8b1EjpBrbLGczc1ddkl9LifF7F7l4Tj7cN6-4AdYK-xK |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatocyte+Expression+of+the+Senescence+Marker+p21+Is+Linked+to+Fibrosis+and+an+Adverse+Liver-Related+Outcome+in+Alcohol-Related+Liver+Disease&rft.jtitle=PloS+one&rft.date=2013-09-23&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=8&rft.issue=9&rft.spage=e72904&rft_id=info:doi/10.1371%2Fjournal.pone.0072904&rft.externalDocID=A478132756 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |